MEDRELEAF CORP. is a licensed producer of cannabisbased pharmaceutical products. The Company cultivates and produces its cannabis-based pharmaceutical products including dried cannabis, cannabis oils, and cannabis oil capsules.

Find Out More
 • Chart
 • News
 • Stock today
 • Price Reports
 • Financial Reports
 • Price History
 • Estimate Reports
 • Add To Your Stocklist
 • View your Stocklist
Click here to print this page.
Symbol: LEAF
Exchange(s): Toronto Stock Exchange
Industry: Agriculture (Other Agricultural Products)
5-Star Rating:
  Mar 31, 2017
12 Months
Mar 31, 2016
12 Months
Mar 31, 2015
12 Months
% Change
Total Revenue ($000) 40,414 19,353 3,014 N/A
Earnings before Interest & Tax ($000) 15,763 3,489 -647 N/A
Profit/Loss ($000) 10,958 2,531 -724 N/A
Earnings per Share 16.35 4.40 -1.64 N/A
Total Assets ($000) 74,885 20,011 8,882 N/A
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity 33.24 29.10 N/A  
Employees 135 133 N/A  
Trailing 12 Month Results
  12 Months ended
Dec 31, 2017, C$
Total Revenue ($000) N/A N/A
Profit/Loss ($000) N/A N/A
Earnings per Share N/A N/A
Dividends Per Share 0.00
Number of Shares 94,798,783  
Report on Business Magazine Top 1000 Ranking
Profit:  0 Revenue:  0 Assets:   0  
Contact Information
Address: 200 Bay Street,
Suite 3800,
M5J 2Z4
Phone: 289-317-1004
Web Address:
E-Mail :
Company Type: Public Company Status: Active
Auditors: Kpmg Llp
Transfer Agent: Tsx Trust Company
Incorporation: Canada, Feb 28, 2013
Securities: LEAF-T
Top Companies in Other Agricultural Products (Selected by Assets)
Aphria Inc. CannTrust Holdings Sunniva Inc.
TerrAscend Corp. Hydropothecary Corp. (The) WeedMD Inc.
Invictus MD Strategies Friday Night Inc. Organto Foods Inc.

All information on this site is compiled by The Globe and Mail Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, The Globe and Mail Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.

Copyright © 2018 The Globe and Mail Inc. All rights reserved.